Skip to content

ECP test paper for predicting eosinophilic chronic sinusitis with nasal polyps: a prospective study

ECP test paper for predicting eosinophilic chronic sinusitis with nasal polyps: a prospective study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025380
Enrollment
Unknown
Registered
2019-08-25
Start date
2019-08-23
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic sinusitis with nasal polyps

Interventions

Gold Standard:pathology
Index test:ECP&#32
test&#32
paper&#32
and&#32
pathology

Sponsors

The Third Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient has at least 3 months of nasal congestion, purulent sputum, decreased olfactory, headache, etc., and confirmed by sinus CT, nasal endoscopy, anterior nasal examination, etc., unilateral or bilateral nasal nasal polyps, age Greater than or equal to 18 years of age can participate in this study.

Exclusion criteria

Exclusion criteria: 1. If the patient has used drugs such as steroids that interfere with Eos within 1 month before enrollment, he has undergone endoscopic sinus surgery for CRSwNP, combined with fungal rhinitis, allergic rhinitis, nasal inverted papilloma, etc. Nasal disease, CRSwNP patients with unreasonable expectation of treatment effect or other mental illness, do not accept ECP test strips to detect nasal secretions, etc. can not participate in this study; 2. The chief physician of our hospital thinks that it is not suitable for participation.

Design outcomes

Primary

MeasureTime frame
pathology;ECP test paper;N/A;

Countries

China

Contacts

Public ContactWeihao Wang

The Third Affiliated Hospital of Sun Yat-Sen University

weihaowong@163.com+86 15626495922

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026